Local

Myocarditis: CDC to discuss reports of heart inflammation in young people after COVID vaccines

The Washington-CDC Advisory Board will be convened at an emergency meeting next week to discuss reports of heart inflammation in adolescents who have received COVID-19. vaccine..

According to the CDC, 226 confirmed cases of this condition, called myocarditis, Pfizer or Moderna COVID-19 vaccine..

Myocarditis tends to be temporary and resolves with treatment and monitoring, but the CDC analyzes these cases to see if they are associated with vaccination.

Dr. Tom Shimabukuro of the CDC’s Vaccination Safety Agency said there was an “imbalance” in the number of cases, but said he needed to confirm further details with the FDA Advisory Board.

“Observed reports are better than expected-based on background, known background rates published in the literature,” he told the FDA Advisory Board this week.

“The comparison between apples and oranges is small, as this is also a preliminary report. Not all of these are reports of true myocarditis or pericarditis,” he added.

More than 800 unidentified cases of heart problems have been reported to the Vaccine Safety Surveillance System, but the CDC says it is most concerned about people under the age of 30. In that age group, officials say the number of myocarditis and pericarditis is higher than normal, there are 226 confirmed cases. The CDC Advisory Board will be up to date on these reports at next week’s meeting.

The· CDC is still recommended Anyone over the age of 12 will be vaccinated against COVID-19, but anyone experiencing chest pain, shortness of breath, or tachycardia within a week of being vaccinated should see a doctor. Say there is.

Side effects are still considered to be rare among the millions of vaccinated people, but because the number is higher than the number of people expected to develop the condition of the general population, with the authorities. External experts are watching carefully to determine if it is related to the vaccine.
Independent experts advising the CDC and FDA are considering questions about the risks and benefits of making vaccines available to children. They want to make sure that there is enough data to ensure that the benefits of vaccination outweigh the possible side effects, even if the country wants to vaccinate a larger population to reach herd immunity. I will.

Conversation and ongoing research balance the risk to children from being infected with COVID-19, which includes a disease called MIS-C, due to the potential for more serious side effects of the vaccine.

Clinical trials have shown that the COVID-19 vaccine is safe and effective against the adult virus.Pfizer vaccine is currently available Allowed for children over 12 years old Clinical trials have shown that it is safe for teens.Says there are experts There is no reason for the vaccine to affect Puberty or childbirth.

in the meantime, A study testing Pfizer and Moderna vaccines in children Currently under 12 years of age is underway and data is expected to be available by the fall. An FDA adviser said this week that despite the urgency of reaching herd immunity, there is no reason to rush the trial in infants.

The CDC Advisory Board is not expected to change vaccine recommendations or vote on the timeline for when the COVID-19 vaccine will be approved by children, but reports of myocarditis are related to the vaccine. Discuss any additional data needed to determine if you have one.

Sony Salzman and Sasha Pezenik of ABC News contributed to this report.

Copyright © 2021 ABCNews Internet Ventures.



Myocarditis: CDC to discuss reports of heart inflammation in young people after COVID vaccines Source link Myocarditis: CDC to discuss reports of heart inflammation in young people after COVID vaccines

Related Articles

Back to top button